264 related articles for article (PubMed ID: 19185566)
1. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
[TBL] [Abstract][Full Text] [Related]
2. Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants.
Zhu HJ; Markowitz JS
Drug Metab Dispos; 2009 Feb; 37(2):264-7. PubMed ID: 19022936
[TBL] [Abstract][Full Text] [Related]
3. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
Thomsen R; Rasmussen HB; Linnet K;
Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
[TBL] [Abstract][Full Text] [Related]
5. CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.
Zhu HJ; Langaee TY; Gong Y; Wang X; Pepine CJ; Cooper-DeHoff RM; Johnson JA; Markowitz JS
Eur J Clin Pharmacol; 2016 Jun; 72(6):681-7. PubMed ID: 26915813
[TBL] [Abstract][Full Text] [Related]
6. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
Zhu HJ; Wang X; Gawronski BE; Brinda BJ; Angiolillo DJ; Markowitz JS
J Pharmacol Exp Ther; 2013 Mar; 344(3):665-72. PubMed ID: 23275066
[TBL] [Abstract][Full Text] [Related]
7. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
[TBL] [Abstract][Full Text] [Related]
8. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.
Zhu HJ; Patrick KS; Yuan HJ; Wang JS; Donovan JL; DeVane CL; Malcolm R; Johnson JA; Youngblood GL; Sweet DH; Langaee TY; Markowitz JS
Am J Hum Genet; 2008 Jun; 82(6):1241-8. PubMed ID: 18485328
[TBL] [Abstract][Full Text] [Related]
9. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
[TBL] [Abstract][Full Text] [Related]
10. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
Wang X; Her L; Xiao J; Shi J; Wu AH; Bleske BE; Zhu HJ
Clin Transl Sci; 2021 Jul; 14(4):1380-1389. PubMed ID: 33660934
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.
Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
[TBL] [Abstract][Full Text] [Related]
12. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
13. Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine.
Imai T; Taketani M; Shii M; Hosokawa M; Chiba K
Drug Metab Dispos; 2006 Oct; 34(10):1734-41. PubMed ID: 16837570
[TBL] [Abstract][Full Text] [Related]
14. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Merali Z; Ross S; Paré G
Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
[TBL] [Abstract][Full Text] [Related]
15. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.
Crow JA; Herring KL; Xie S; Borazjani A; Potter PM; Ross MK
Biochim Biophys Acta; 2010 Jan; 1801(1):31-41. PubMed ID: 19761868
[TBL] [Abstract][Full Text] [Related]
17. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
[TBL] [Abstract][Full Text] [Related]
18. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
Ishizuka T; Yoshigae Y; Murayama N; Izumi T
Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
[TBL] [Abstract][Full Text] [Related]
19. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
Laizure SC; Parker RB; Herring VL; Hu ZY
Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
[TBL] [Abstract][Full Text] [Related]
20. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
